Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05125003 · ClinicalTrials.gov registry record · NA

Family-Implemented Treatment on the Behavioral Inflexibility of Children With Autism

A NA study of Autism Spectrum Disorder and Repetitive Compulsive Behavior, sponsored by University of Kansas.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05125003 is a NA study of Autism Spectrum Disorder and Repetitive Compulsive Behavior that is actively recruiting participants, run by University of Kansas. The registered enrollment target is 100 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05125003, a NA study of Autism Spectrum Disorder and Repetitive Compulsive Behavior, is actively recruiting participants, sponsored by University of Kansas.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this project is to determine whether a new form of family-based treatment for repetitive and inflexible behaviors, delivered using videoconferencing technology, can counter any negative effects of those behaviors, but also improve positive outcomes for young children with ASD.

Interventions

  • BEHAVIORAL FITBI
  • BEHAVIORAL Parental Education

Study Locations (1)

Kansas

  • Juniper Gardens Children's Project - Kansas City

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-04-01
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Kansas

66 total trials

What the Registry Record Tells You About NCT05125003

The ClinicalTrials.gov registry entry for NCT05125003 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (26% lower). The listed sponsor is University of Kansas, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which FITBI is the first listed.

NCT05125003 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT05125003 about?

NCT05125003 is a clinical study titled "Family-Implemented Treatment on the Behavioral Inflexibility of Children With Autism". The overall goal of this project is to determine whether a new form of family-based treatment for repetitive and inflexible behaviors, delivered using videoconferencing technology, can counter any negative effects of those behaviors, but also improve positive outcomes for young children with ASD.

What is the current status of trial NCT05125003?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-04-01. Estimated completion is 2026-03-31.

What conditions does trial NCT05125003 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Repetitive Compulsive Behavior.

What interventions are being tested in trial NCT05125003?

The interventions under investigation include: FITBI (BEHAVIORAL), Parental Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05125003?

This trial is sponsored by University of Kansas, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05125003 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.